Skip to main content
Have a personal or library account? Click to login
Secondary Haemophagocytic Lymphohistiocytosis – The Differential Diagnosis Dilemma In Paediatrics Cover

Secondary Haemophagocytic Lymphohistiocytosis – The Differential Diagnosis Dilemma In Paediatrics

EABR. Experimental and Applied Biomedical Research
Volume 16 (2015): Issue 1 (March 2015)
By: ,  ,  ,  ,   and    
Open Access
|Apr 2015
References

References

  1. 1. Lipton JM, Arceci RJ. Histiocytic disorders. In: Hoffman R, Edward B, eds. Hematology: basic principles and practice. 4ed. Philadelphia: Churchill Livingstone. 2005; 857–67.
    Search in Google Scholar
  2. 2. Ladisch S. Histiocytosis syndrome in childhood. In: Behrman ER, Kliegman MR, Jenson BH. NELSON Textbook of pediatrics, vol 2, 17th ed. Belgrade: Saunders, Bard 2009; 1727–30. (translated)
    Search in Google Scholar
  3. 3. Favara BE, Feller AC, Pauli M et al. Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol. 1997; 29(3): 157–66.
    Open DOISearch in Google Scholar
  4. 4. Verbsky JW, Grossman WJ. Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives. Ann Med. 2006; 38(1): 20–31.
    Open DOISearch in Google Scholar
  5. 5. Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev Med. 2012; (63): 233–46.
    Open DOISearch in Google Scholar
  6. 6. Feldmann J, Le Deist F, Ouachée–Chardin M et al. Functional consequences of perforin gene mutations in 22 patients with familial haemophagocytic lymphohistiocytosis. Br J Haematol. 2002; 117(4): 965–72.
    Open DOISearch in Google Scholar
  7. 7. Feldmann J, Callebaut I, Raposo G et al. Munc 13–4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell. 2003; 115(4): 461–73.
    Open DOISearch in Google Scholar
  8. 8. Ohadi M, Lalloz MR, Sham P et al. Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3–22 by homozygosity mapping. Am J Hum Genet. 1999; 64(1): 165–71.
    Open DOISearch in Google Scholar
  9. 9. Dufourcq–Lagelouse R, Jabado N, Le Deist F et al. Linkage of familial hemophagocytic lymphohistiocytosis to 10q21–22 and evidence for heterogeneity. Am J Hum Genet. 1999 Jan; 64(1): 172–9.
    Open DOISearch in Google Scholar
  10. 10. Stepp SE, Dufourcq–Lagelouse R, Le Deist F et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999; 286(5446): 1957–9.
    Open DOISearch in Google Scholar
  11. 11. Kogawa K, Lee SM, Villanueva J, Marmer D, Sumegi J, Filipovich AH. Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood. 2002; 99(1): 61–6
    Open DOISearch in Google Scholar
  12. 12. Ansuini V, Rigante D, Esposito S. Debate around infection–dependent hemophagocytic syndrome in pediatrics. BMC Infect Dis. 2013; (13): 13–15.
    Open DOISearch in Google Scholar
  13. 13. Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis. 2000; 6(6): 601–8.
    Open DOISearch in Google Scholar
  14. 14. Janka G, Imashuku S, Elinder G, Schneider M, Henter JI. Infection– and malignancy–associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am. 1998; 12(2): 435–44.
    Open DOISearch in Google Scholar
  15. 15. Danish EH, Dahms BB, Kumar ML. Cytomegalovirus– associated hemophagocytic syndrome. Pediatrics. 1985; 75(2): 280-3.
    Open DOISearch in Google Scholar
  16. 16. Bhatia S, Bauer F, Bilgrami SA. Candidiasis–associated hemophagocytic lymphohistiocytosis in a patient infected with human immunodeficiency virus. Clin Infect Dis. 2003; 37(11): 161–6.
    Open DOISearch in Google Scholar
  17. 17. Watanabe T, Okazaki E, Shibuya H. Influenza A virus– associated encephalopathy with haemophagocytic syndrome. Eur J Pediatr. 2003; 162(11): 799–800.
    Open DOISearch in Google Scholar
  18. 18. Kaya Z, Oztürk G, Gürsel T, Bozdayi G. Spontaneous resolution of hemophagocytic syndrome and disseminated intravascular coagulation associated with Parvovirus B19 infection in a previously healthy child. Jpn J Infect Dis. 2005; 58(3): 149–51.
    Search in Google Scholar
  19. 19. Tuon FF, Gomes VS et al. Hemophagocytic syndrome associated with hepatitis A: case report and literature review. Rev Inst Med Trop Sao Paulo. 2008; 50(2): 123–7.
    Open DOISearch in Google Scholar
  20. 20. Brastianos PK, Swanson JW, Torbenson M, Sperati J, Karakousis PC. Tuberculosis–associated haemophagocytic syndrome. Lancet Infect Dis. 2006; 6(7): 447–54.
    Open DOISearch in Google Scholar
  21. 21. Cascio A, Giordano S, Dones P, Venezia S, Iaria C, Ziino O. Haemophagocytic syndrome and rickettsial diseases. J Med Microbiol. 2011; 60(Pt 4): 537–42.
    Open DOISearch in Google Scholar
  22. 22. Gosh JB, Roy M, Bala A. Infection associated with Hemophagocytic Lymphohistiocytosis triggered by nosocomial infection. Oman Med J. 2009; 24(3): 223–5.
    Search in Google Scholar
  23. 23. Cascio A, Pernice LM et al. Secondary hemophagocytic lymphohistiocytosis in zoonoses. A systematic review. Eur Rev Med Pharmacol Sci. 2012; 16(10): 1324–37.
    Search in Google Scholar
  24. 24. Gagnaire MH, Galambrun C, Stéphan JL. Hemophagocytic syndrome: a misleading complication of visceral leishmaniasis in children – a series of 12 cases. Pediatrics. 2000; 106(4): E58.
    Open DOISearch in Google Scholar
  25. 25. Onishi R, Namiuchi S. Hemophagocytic syndrome in a patient with rheumatoid arthritis. Intern Med. 1994; 33(10): 607–11.
    Open DOISearch in Google Scholar
  26. 26. Wong KF, Hui PK, Chan JK, Chan YW, Ha SY. The acute lupus hemophagocytic syndrome. Ann Intern Med. 1991; 114(5): 387–90.
    Open DOISearch in Google Scholar
  27. 27. Henter JI, Horhe A, Arico M et al. HLH–2004: Diagnostic an therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Pediatr Blood Cancer. 2007; 48(2): 124–31.
    Open DOISearch in Google Scholar
  28. 28. Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol. 1991; 18(1): 29–33.
    Search in Google Scholar
  29. 29. Rosado FG, Kim AS. Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis. Am J Clin Pathol. 2013; 139(6):713–27.
    Open DOISearch in Google Scholar
  30. 30. Tang YM, Xu XJ. Advances in hemophagocytic lymphohistiocytosis: pathogenesis, early diagnosis/differential diagnosis, and treatment. Scientific World Journal. 2011; 11: 697–708.
    Open DOISearch in Google Scholar
  31. 31. Konuş OL, Ozdemir A, Akkaya A, Erbaş G, Celik H, Işik S. Normal liver, spleen and kidney dimensions in neonates, infants, and children: evaluation with sonography. AJR Am J Roentgenol. 1998; 171(6): 1693–8.
    Open DOISearch in Google Scholar
  32. 32. Rademacher C, Hartmann D, Spiethoff A, Jakobs R. Ferritin and soluble interleukin–2–receptor in the diagnosis of fever of unknown origin. Dtsch Med Wochenschr. 2014; 139(1-2): 23–7.
    Open DOISearch in Google Scholar
  33. 33. Lehmberg K, McClain KL, Janka GE, Allen CE. Determination of an appropriate cut-off value for ferritin in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2014 Apr 21. [Epub ahead of print] PubMed PMID: 24753034.
    Open DOISearch in Google Scholar
  34. 34. Imashuku S, Hibi S et al. Soluble interleukin-2 receptor: a useful prognostic factor for patients with hemophagocytic lymphohistiocytosis. Blood. 1995; 86(12): 4706–7.
    Open DOISearch in Google Scholar
  35. 35. Wang LL, Hu YX, Chen WF et al. Significance of soluble interleukin-2 receptor and NK cell activity in patients with hemophagocytic lymphohistiocytosis. Zhongguo Shi Yan Xue Ye XueZaZhi. 2012; 20(2): 401–4.
    Search in Google Scholar
  36. 36. Sloma I, Vincent H, Addebbous A, Rivoisy C, Turhan GA, Michot JM. Haemophagocytic histiocyte in a peripheral blood film. Br J Haematol. 2014; 165(2): 163.
    Open DOISearch in Google Scholar
  37. 37. Jabado N, McCusker C, BasileGde S. Pediatric hemophagocytic syndromes: a diagnostic and therapeutic challenge. Allergy Asthma Clin Immunol. 2005; 1(4): 142–60.
    Search in Google Scholar
  38. 38. Kobayashi S, Ito M, Sano H et al. Clinical analysis of combination therapy for febrile neutropenic patients in childhood cancer. Pediatr Int. 2013; 55(1): 65–71.
    Open DOISearch in Google Scholar
  39. 39. Raghavendra M, Hoeg RT, Bottner WA, Agger WA. Management of neutropenic fever during a transition from traditional hematology/oncology service to hospitalist care. WMJ. 2014; 113(2): 53–8.
    Search in Google Scholar
  40. 40. Hung KC, Chiu HH, Tseng YC et al. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empirical therapy for neutropenic fever in children with malignancy. J Microbiol Immunol Infect. 2003; 36(4): 254–9.
    Search in Google Scholar
  41. 41. Biondi E, McCulloh R, Alverson B, Klein A, Dixon A, Ralston S. Treatment of Mycoplasma Pneumonia: A Systematic Review. Pediatrics. 2014; 133(6):1081–90.
    Open DOISearch in Google Scholar
  42. 42. Aytaç S, Yildirim I, Ceyhan M et al. Risks and outcome of fungal infection in neutropenic children with hematologic diseases. Turk J Pediatr. 2010; 52(2): 121–5.
    Search in Google Scholar
  43. 43. Rajajee S, Ashok I, Manwani N, Rajkumar J, Gowrishankar K, Subbiah E. Profile of Hemophagocytic Lymphohistiocytosis; Efficacy of Intravenous Immunoglobulin Therapy. Indian J Pediatr. 2014 May 9. [Epub ahead of print] PubMed PMID: 24806152.
    Open DOISearch in Google Scholar
  44. 44. Scott R, Robb-Smith A. Histiocytic medullary reticulosis. Lancet. 1939; (2): 194–8.
    Open DOISearch in Google Scholar
  45. 45. Farquhar J, Claireaux A. Familial haemophagocytic reticulosis. Arch Dis Child. 1952; 27(136): 519–525.
    Open DOISearch in Google Scholar
  46. 46. Boake WC; Card WH, Kimmey JF. Histiocytic Medullary Reticulosis, Concurrence in Father and Son. Arch Intern Med. 1965; 116(2): 245–52.
    Open DOISearch in Google Scholar
  47. 47. Henter JI, Ehrnst A, Andersson J, Elinder G. Familial hemophagocytic lymphohistiocytosis and viral infections. Acta Paediatr. 1993; 82(4): 369–372.
    Open DOISearch in Google Scholar
  48. 48. Vaiselbuh SR, Bryceson YT, Allen CE, Whitlock JA, Abla O. Updates on histiocytic disorders. Pediatr Blood Cancer. 2014; 61(7): 1329–35.
    Open DOISearch in Google Scholar
  49. 49. Janka GE, Lehmberg K. Hemophagocytic lymphohistiocytosis: pathogenesis and treatment. Hematology Am Soc Hematol Educ Program. 2013; 2013: 605–11.
    Open DOISearch in Google Scholar
  50. 50. Chandrakasan S, Filipovich AH. Hemophagocytic lymphohistiocytosis: advances in pathophysiology, diagnosis and treatment. J Pediatr. 2013; 163(5): 1253–9.
    Open DOISearch in Google Scholar
  51. 51. Balwierz W, Czogała M, Pawińska–Wasikowska K, Cwiklińska M, Walicka–Soja K. Hemophagocytic lymphohistiocytosis: diagnostic problems in pediatrics. Przegl Lek. 2010; 67(6): 417–24.
    Search in Google Scholar
  52. 52. Real E, Gomez A, Alcaraz MJ, Saez AI, Pastor E, Grau E. Fulminant hemophagocytic syndrome as presenting feature of T–cell lymphoma and Epstein–Barr virus infection. Haematologica. 2000; 85(4): 439–40.
    Search in Google Scholar
  53. 53. Usmani GN, Woda BA, Newburger PE. Advances in understanding the pathogenesis of HLH. Br J Haematol. 2013; 161(5): 609–22.
    Open DOISearch in Google Scholar
  54. 54. Guo X, Li Q, Zhou CY, Zhao YN. Clinical analysis of Epstein–Barr virus–associated hemophagocytic syndrome in children. Zhongguo Shi Yan Xue Ye XueZa-Zhi. 2013; 21(2): 460–4.
    Search in Google Scholar
  55. 55. Liapis K, Apostolidis J, Delimpasis S. EBV–associated hemophagocytic syndrome. Am J Hematol. 2011; 86(5): 422.
    Open DOISearch in Google Scholar
  56. 56. Henter JI, Nennesmo I. Neuropathologic findings and neurologic symptoms in twenty–three children with hemophagocytic lymphohistiocytosis. J Pediatr. 1997; 130(3): 358–65.
    Open DOISearch in Google Scholar
  57. 57. Haddad E, Sulis ML, Jabado N, Blanche S, Fischer A, Tardieu M. Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood. 1997; 89(3): 794–800.
    Open DOISearch in Google Scholar
  58. 58. Janković G. Aplastic anemia. In: D. Manojlovic. Internal Medicine, 5th ed. Belgrade: The Institute for Textbooks, 2009; 1019–21.
    Search in Google Scholar
  59. 59. Čolović M. Leucemias. In: D. Manojlovic. Internal Medicine, 5th ed. Belgrade: The Institute for Textbooks, 2009; 1031–43.
    Search in Google Scholar
  60. 60. Aulbert E, Fromm H, Hornemann H. Ferritin in acute leukemia. Serum ferritin concentration as a nonspecific tumor marker for M1 and M2 myeloid leukemia. Med Klin (Munich). 1991; 86(6): 297–304.
    Search in Google Scholar
  61. 61. Huang SC, Chen JS, Cheng CN, Yang YJ. Hypoalbuminaemia is an independent predictor for hemophagocytic lymphohistiocytosis in childhood Epstein–Barr virus– associated infectious mononucleosis. Eur J Haematol. 2012; 89(5): 417–22.
    Open DOISearch in Google Scholar
  62. 62. Eid A, Keddissi JI, Kinasewitz GT. Hypoalbuminemia as a cause of pleural effusions. Chest 1999; 115(4): 1066-9.
    Open DOISearch in Google Scholar
  63. 63. Tutor JD. Chylothorax in infants and children. Pediatrics. 2014; 133(4):722–33.
    Open DOISearch in Google Scholar
  64. 64. Popović G. Pleural effusions: a special review of pleural effusions in extrapulmonary disease. Pneumon 2010; 47(1-2): 73–80.
    Search in Google Scholar
  65. 65. Kogawa K, Sato H, Asano T et al. Prognostic factors of Epstein–Barr virus–associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group. Pediatr Blood Cancer. 2014; 61(7): 1257–62.
    Open DOISearch in Google Scholar
  66. 66. Ishii E, Ohga S et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol. 2007; 86(1): 58–65.
    Open DOISearch in Google Scholar
  67. 67. Chen CJ, Huang YC et al. Hemophagocytic syndrome: a review of 18 pediatric cases. J Microbiol Immunol Infect. 2004; 37(3): 157–63.
    Search in Google Scholar
  68. 68. Bakhshi S, Pautu JL. EBV associated hemophagocytic lymphohistiocytosis with spontaneous regression. Indian Pediatr. 2005; 42(12): 1253–5.
    Search in Google Scholar
  69. 69. Imashuku S. Treatment of Epstein–Barr virus–related hemophagocytic lymphohistiocytosis (EBV–HLH); update 2010. J Pediatr Hematol Oncol. 2011; 33(1): 35–9.
    Open DOISearch in Google Scholar
  70. 70. Marsh RA, Jordan MB, Filipovich AH. Reduced–intensity conditioning haematopoetic cell transplantation for haemophagocytic lymphohistiocytosis: an important step forward. Br J Haematol. 2011; 154(5): 556–63.
    Open DOISearch in Google Scholar
  71. 71. Shiraishi A, Ohga S, Doi T et al. Treatment choice of immunotherapy or further chemotherapy for Epstein–Barr virus–associated hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2012; 59(2): 265–70.
    Open DOISearch in Google Scholar
  72. 72. Balamuth NJ, Nichols KE, Paessler M, Teachey DT. Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus–associated hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol. 2007; 29(8): 569–73.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/sjecr-2015-0009 | Journal eISSN: 2956-2090 (formerly 2335-075X, 2956-0454) | Journal ISSN: 2956-0454 (formerly 1820-8665)
Journal RSS Feed
Language: English
Page range: 55 - 63
Submitted on: Oct 1, 2014
Accepted on: Dec 29, 2014
Published on: Apr 4, 2015
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Keywords:
haemophagocytic lymphohistiocytosis,
Epstein–Barr virus,
children
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2015 Rasa Medovic, Biljana Vuletic, Zorica Raskovic, Aleksandra Simovic, Jelena Nestorovic–Tanaskovic, Zoran Igrutinovic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 16 (2015): Issue 1 (March 2015)
Previous article
Next article